Evidence map›Paper›PMID 35173179›Full record

ArticleScientific reports2022

Depressive symptoms reduce when dorsolateral prefrontal cortex-precuneus connectivity normalizes after functional connectivity neurofeedback.

Jessica Elizabeth Taylor, Takashi Yamada, Takahiko Kawashima, Yuko Kobayashi, Yujiro Yoshihara, Jun Miyata, Toshiya Murai, Mitsuo Kawato, Tomokazu Motegi

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it, 53 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Effectiveness of fMRI-based Neurofeedback Therapy on Depression: A Systematic Review.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2025
    Review
  11. Article
  12. Towards an expanded neurocognitive account of ketamine's rapid antidepressant effects.The international journal of neuropsychopharmacology · 2025
    Review
  13. Review
  14. Article
  15. Article
  16. Amygdala self-neuromodulation capacity as a window for process-related network recruitment.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2024
    Article
  17. Article
  18. Article
  19. Targeted neurorehabilitation strategies in post-stroke aphasia.Restorative neurology and neuroscience · 2023
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Jessica Elizabeth TaylorDepartment of Decoded Neurofeedback (DecNef), Computational Neuroscience Laboratories, Advanced Telecommunications Research Institute International (ATR), Hikaridai 2-2-2. Seika-cho, Soraku, Kyoto, 619-0237, Japan.
Takashi YamadaDepartment of Decoded Neurofeedback (DecNef), Computational Neuroscience Laboratories, Advanced Telecommunications Research Institute International (ATR), Hikaridai 2-2-2. Seika-cho, Soraku, Kyoto, 619-0237, Japan.
Takahiko KawashimaDepartment of Psychiatry, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Yuko KobayashiDepartment of Psychiatry, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Yujiro YoshiharaDepartment of Psychiatry, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Jun MiyataDepartment of Psychiatry, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Toshiya MuraiDepartment of Psychiatry, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Mitsuo KawatoDepartment of Decoded Neurofeedback (DecNef), Computational Neuroscience Laboratories, Advanced Telecommunications Research Institute International (ATR), Hikaridai 2-2-2. Seika-cho, Soraku, Kyoto, 619-0237, Japan.
Tomokazu MotegiDepartment of Decoded Neurofeedback (DecNef), Computational Neuroscience Laboratories, Advanced Telecommunications Research Institute International (ATR), Hikaridai 2-2-2. Seika-cho, Soraku, Kyoto, 619-0237, Japan. motegi@atr.jp.
Kyoto University · JPAdvanced Telecommunications Research Institute International · JPBrown University · USGunma University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Depressive disorders contribute heavily to global disease burden; This is possibly because patients are often treated homogeneously, despite having heterogeneous symptoms with differing underlying neural mechanisms. A novel treatment that can directly influence the neural circuit relevant to an individual patient's subset of symptoms might more precisely and thus effectively aid in the alleviation of their specific symptoms. We tested this hypothesis in a proof-of-concept study using fMRI functional connectivity neurofeedback. We targeted connectivity between the left dorsolateral prefrontal cortex/middle frontal gyrus and the left precuneus/posterior cingulate cortex, because this connection has been well-established as relating to a specific subset of depressive symptoms. Specifically, this connectivity has been shown in a data-driven manner to be less anticorrelated in patients with melancholic depression than in healthy controls. Furthermore, a posterior cingulate dominant state-which results in a loss of this anticorrelation-is expected to specifically relate to an increase in rumination symptoms such as brooding. In line with predictions, we found that, with neurofeedback training, the more a participant normalized this connectivity (restored the anticorrelation), the more related (depressive and brooding symptoms), but not unrelated (trait anxiety), symptoms were reduced. Because these results look promising, this paradigm next needs to be examined with a greater sample size and with better controls. Nonetheless, here we provide preliminary evidence for a correlation between the normalization of a neural network and a reduction in related symptoms. Showing their reproducibility, these results were found in two experiments that took place several years apart by different experimenters. Indicative of its potential clinical utility, effects of this treatment remained one-two months later.Clinical trial registration: Both experiments reported here were registered clinical trials (UMIN000015249, jRCTs052180169).

Indexed as

AdultAnxiety DisordersBrain MappingCase-Control StudiesConnectomeDepressionDorsolateral Prefrontal CortexFemaleHumansMaleNerve NetNeurofeedbackYoung Adult

Identifiers

PMID35173179
PMCPMC8850610
OpenAlexW4212984828

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.